The Global Non-Invasive Prenatal Testing (NIPT) Market is expected to grow at 16% by 2029. The high risk of chromosomal abnormalities with rising maternal age, the surge in the adoption of cell-free ...

Myriad Genetics, Inc. announced it will present significant research on early prenatal testing at the Society for Maternal-Fetal Medicine Conference. The study, awarded the Dru Carlson Memorial Award, ...

When discussing the value of screening for 22q, the authors concluded that, “the PPV of cfDNA for 22q11.2DS is higher and the false positive rate is lower than that associated with other accepted ...

Dublin, Oct. 15, 2025 (GLOBE NEWSWIRE) -- The "Prenatal and Newborn Genetic Testing Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive ...

Myriad Genetics, Inc. has launched a new educational website called "Know More Sooner," aimed at providing detailed information about reproductive and prenatal genetic testing. The site seeks to ...

A new study indicates that noninvasive prenatal screening (NIPS) performed using a low-cost form of whole genome sequencing can detect the risk in pregnant mothers of transmitting cytomegalovirus (CMV ...

(MENAFN- GlobeNewsWire - Nasdaq) Globally, NIPT is seeing increasing uptake across hospitals and diagnostic laboratories as demand for safer, early fetal screening rise and prenatal care pathways ...

Dublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "United States Non-Invasive Prenatal Testing (NIPT) Market Report 2025: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, ...

The global Prenatal Genetic Testing Market is valued at USD 7.01 billion in 2024 and is projected to reach a value of USD 24.125 billion by 2035 at a CAGR (Compound Annual Growth Rate) of 11.95% ...